OEM News

Philips Rolls Out Transcend Plus for EPIQ CVx and Affiniti CVx Cardiac Ultrasounds

Transcend Plus provides newly FDA-cleared 2D and 3D image quality enhancements and a growing suite of AI-enabled clinical applications.

Author Image

By: Sam Brusco

Associate Editor

Transcend Plus ultrasound system in use. Photos: Philips.

Philips has released Transcend Plus, the next generation of its EPIQ CVx and Affiniti Cvx cardiovascular ultrasound systems.

Transcend Plus provides newly U.S. Food and Drug Administration (FDA)-cleared 2D and 3D image quality enhancements and a growing suite of artificial intelligence (AI)-enabled clinical applications. It’s designed to help cardiology teams work smarter with fast, reproducible results, uncompromising image quality, and decision-making support, according to Philips.

It boosts sharpness, contrast, and detail in 2D and 3D imaging thanks to better visualization of cardiac anatomy and function. The update introduces the 2D Auto EF Advanced feature, which expands AI capabilities for contrast images.

EPIQ CVx system clinical view

Transcend Plus also supports the need for left ventricular (LV) function assessment with automated tools to minimize operator variability. It supports for contrast and non-contrast imaging—the 2D Auto EF feature allows accurate assessments even when contrast agents can’t be used. It also adds AI-powered quantification for both contrast and non-contrast studies to broaden applicability and boost measurement reliability in patients with poor image quality of challenging acoustic windows.

Philips said Transcend Plus delivers three core benefits: enhanced image quality for clearer visualization of cardiac anatomy and improved diagnostic precision; advanced AI integration, with 26 FDA-cleared applications—the most in the industry—that automate and accelerate routine tasks; and faster, more actionable insights that reduce delays and support timely, evidence-based clinical decisions throughout the care journey.

Mini 3D TEE transducer clinical view

“Transcend Plus represents a bold leap forward in the evolution of echocardiography, reinforcing our commitment to continuous innovation, empowering clinicians with AI-driven tools that enhance confidence, accelerate decision-making, and elevate care at every stage of the cardiac journey,” said David Handler, Business Leader, Cardiology Ultrasound at Philips. “Transcend Plus is more than an advancement – it’s a clear statement of Philips’ leadership in cardiovascular ultrasound. Building on the momentum of our original Transcend launch, Transcend Plus brings the full power of AI integration to the forefront, giving clinicians the confidence, speed, and precision they need to lead in cardiac care – today and into the future.”

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters